The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of abivertinib (AC0010), a third-generation EGFR tyrosine kinase inhibitor, in Chinese patients with EGFR-T790M positive non-small cell lung cancer (NCSLC).
 
Qing Zhou
Honoraria - ACEA Pharmaceutical Research
Consulting or Advisory Role - ACEA Pharmaceutical Research
Research Funding - ACEA Pharmaceutical Research (Inst)
 
Lin Wu
Honoraria - ACEA Pharmaceutical Research
Consulting or Advisory Role - ACEA Pharmaceutical Research
Research Funding - ACEA Pharmaceutical Research (Inst)
 
Luo Feng
Honoraria - ACEA Pharmaceutical Research
Consulting or Advisory Role - ACEA Pharmaceutical Research
Research Funding - ACEA Pharmaceutical Research (Inst)
 
Tongtong An
Honoraria - ACEA Pharmaceutical Research
Consulting or Advisory Role - ACEA Pharmaceutical Research
Research Funding - ACEA Pharmaceutical Research (Inst)
 
Ying Cheng
No Relationships to Disclose
 
Jianying Zhou
Honoraria - ACEA Pharmaceutical Research
Consulting or Advisory Role - ACEA Pharmaceutical Research
Research Funding - ACEA Pharmaceutical Research (Inst)
 
Junling Li
Honoraria - ACEA Pharmaceutical Research
Consulting or Advisory Role - ACEA Pharmaceutical Research
Research Funding - ACEA Pharmaceutical Research (Inst)
 
Ji Feng Feng
Honoraria - ACEA Pharmaceutical Research
Consulting or Advisory Role - ACEA Pharmaceutical Research
Research Funding - ACEA Pharmaceutical Research (Inst)
 
Li Zhang
Honoraria - ACEA Pharmaceutical Research
Consulting or Advisory Role - ACEA Pharmaceutical Research
Research Funding - ACEA Pharmaceutical Research (I)
 
Baohui Han
No Relationships to Disclose
 
Walson Xu
Employment - ACEA Pharmaceutical Research
Leadership - ACEA Pharmaceutical Research
Stock and Other Ownership Interests - ACEA Pharmaceutical Research
Travel, Accommodations, Expenses - ACEA Pharmaceutical Research
 
Lvyu Zhu
Employment - ACEA Pharmaceutical Research
Leadership - ACEA Pharmaceutical Research
Stock and Other Ownership Interests - ACEA Pharmaceutical Research
Travel, Accommodations, Expenses - ACEA Pharmaceutical Research
 
Li Xu
Employment - ACEA Therapeutics
Leadership - ACEA Therapeutics
Stock and Other Ownership Interests - ACEA Therapeutics
Travel, Accommodations, Expenses - ACEA Therapeutics
 
Xiao Xu
Employment - ACEA Therapeutics
Leadership - ACEA Therapeutics
Stock and Other Ownership Interests - ACEA Therapeutics
Travel, Accommodations, Expenses - ACEA Therapeutics
 
Feng Roger Luo
Employment - ACEA Therapeutics
Leadership - ACEA Pharmaceutical Research
Stock and Other Ownership Interests - ACEA Therapeutics
Travel, Accommodations, Expenses - ACEA Therapeutics
 
Yi-Long Wu
Honoraria - AstraZeneca; Boehringer Ingelheim; Lilly; Pfizer; Roche; Sanofi
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Merck; Roche
Research Funding - Boehringer Ingelheim (Inst); Roche (Inst)